Xponance’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $537K | Sell |
7,193
-39
| -0.5% | -$2.91K | ﹤0.01% | 921 |
|
|
2025
Q1 | $460K | Sell |
7,232
-14
| -0.2% | -$890 | ﹤0.01% | 960 |
|
|
2024
Q4 | $566K | Buy |
7,246
+404
| +6% | +$31.5K | 0.01% | 915 |
|
|
2024
Q3 | $550K | Buy |
6,842
+32
| +0.5% | +$2.57K | 0.01% | 910 |
|
|
2024
Q2 | $563K | Sell |
6,810
-444
| -6% | -$36.7K | 0.01% | 875 |
|
|
2024
Q1 | $619K | Sell |
7,254
-103
| -1% | -$8.79K | 0.01% | 881 |
|
|
2023
Q4 | $629K | Buy |
7,357
+93
| +1% | +$7.95K | 0.01% | 848 |
|
|
2023
Q3 | $651K | Sell |
7,264
-117
| -2% | -$10.5K | 0.01% | 791 |
|
|
2023
Q2 | $628K | Sell |
7,381
-468
| -6% | -$39.8K | 0.01% | 820 |
|
|
2023
Q1 | $650K | Sell |
7,849
-34
| -0.4% | -$2.81K | 0.01% | 818 |
|
|
2022
Q4 | $620K | Sell |
7,883
-76
| -1% | -$5.98K | 0.01% | 816 |
|
|
2022
Q3 | $589K | Buy |
7,959
+10
| +0.1% | +$740 | 0.01% | 774 |
|
|
2022
Q2 | $518K | Buy |
7,949
+513
| +7% | +$33.4K | 0.01% | 843 |
|
|
2022
Q1 | $470K | Sell |
7,436
-68
| -0.9% | -$4.3K | 0.01% | 918 |
|
|
2021
Q4 | $398K | Sell |
7,504
-82
| -1% | -$4.35K | 0.01% | 981 |
|
|
2021
Q3 | $535K | Sell |
7,586
-416
| -5% | -$29.3K | 0.01% | 853 |
|
|
2021
Q2 | $533K | Sell |
8,002
-2,317
| -22% | -$154K | 0.01% | 899 |
|
|
2021
Q1 | $1.15M | Buy |
10,319
+204
| +2% | +$22.7K | 0.02% | 438 |
|
|
2020
Q4 | $1.2M | Sell |
10,115
-6
| -0.1% | -$712 | 0.03% | 421 |
|
|
2020
Q3 | $883K | Buy |
10,121
+779
| +8% | +$68K | 0.02% | 446 |
|
|
2020
Q2 | $837K | Buy |
+9,342
| New | +$837K | 0.02% | 426 |
|